NCT06291909Active, not recruiting
Small Steps Towards Improving Activity and Sleep Habits to Decrease the Risk of Dementia
Small Steps Towards Personalized Dementia Prevention: Implementation and Evaluation of a Personalized, Technology-assisted Physical Behaviour Intervention
Source: ClinicalTrials.gov · Last updated 17 Sept 2025
Brief summary (registry, in English)
This is a randomised controlled study aiming to evaluate the implementation of a website ('Small Steps') to support the modification of participants' time-use behaviour to reduce the risk factors for dementia. 'Small Steps' website provides the tools for this with a visual representation of the participant's current use of time and allowing manipulation to demonstrate how small lifestyle changes may improve and meet sleep and physical activity needs. Participants will be assisted to make changes to current behaviours with the aim to reduce the time they spend sitting (sedentary behaviour), increase physical activity, and improve sleep duration and quality. Participants (aged 65 or older) will be randomly allocated to one of two groups, the 'Extended Program' (intervention) group or the 'Condensed Program' (control) group. There are 3 phases (Introductory, Maintenance and Follow-Up; each 12-weeks long) to this program and in total the program is 36-weeks long. Participants will use a tailored website to help support them in making progressive changes over the first 12 weeks. They will then try to maintain these behaviour changes for as long as possible. There will be in-person health testing during each phase and information about sleep habits, sleep quality, and motivation will be assessed using online surveys. Physical activity levels and sleep duration will also be assessed.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- First submitted
- 18 Feb 2024
- Start date
- 3 Apr 2024
- Primary completion date
- 28 Feb 2026
- Lead sponsor
- University of South Australia
- Diseases
- Alzheimer disease
- NCT number
- NCT06291909
What you commit to
- Study type: Interventional
- Planned participants: 88
- From 3 Apr 2024 to the primary completion date, 28 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Scores below the mild cognitive impairment (MCI) cut-off (\<13/22) on the Montreal Cognitive Assessment-Blind (MoCA-B) or a current diagnosis of dementia
- Major neurological or psychiatric diagnosis
Other
- Self-reported meeting the Australian physical activity guidelines
- Known intellectual disability
- Major physical disability
- Lack of English fluency
- Involved in another intervention trial involving physical activity, brain training, and/or diet
- Have vision problems which may prevent them from reading a computer and/or phone screen
Who the study is looking for
- Aged 65 years or older
- Ambulatory and community dwelling
- Fluent in the English Language (required for cognitive assessments)
- Resident of City of Onkaparinga Council, Marion City Council, City of Port Adelaide and Enfield, City of Playford, City of Salisbury, City of Tea Tree Gully
- Access and competency in using technology (i.e., phone, tablet, computer)
- Not meeting the Australian physical activity guidelines - 150 minutes per week of moderate intensity physical activity (self-report)
- Deemed safe to participate in physical activity (ESSA APSS stage 1) or clearance from health professional
Age in the registry: 65 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of South Australia Coordinator of this site? Confirm its status | Adelaide | Australia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.